253 results
8-K
EX-99.1
GOVX
Geovax Labs Inc
1 Mar 24
GeoVax Reports 2023 Year-End Financial Results
4:09pm
vaccine, also in a direct comparison to a mRNA vaccine.
“Results released during 2023 demonstrated the safety and efficacy of GEO-CM04S1 … safety of this therapy and consistent reduction in treated tumors. During first half 2024, we anticipate reporting additional results from the Gedeptin
POS AM
kow5by3 7s
1 Mar 24
Prospectus update (post-effective amendment)
4:04pm
POS AM
7g3qt
1 Mar 24
Prospectus update (post-effective amendment)
4:04pm
POS AM
5yl3gm 52viu0g6d6
1 Mar 24
Prospectus update (post-effective amendment)
4:03pm
POS AM
9qunz6f7
1 Mar 24
Prospectus update (post-effective amendment)
4:03pm
424B3
83a7156vbefuf
12 Jan 24
Prospectus supplement
4:00pm
8-K
EX-99.1
8cphuw64 ojup
9 Nov 23
GeoVax Reports Third Quarter 2023 Financial Results and Provides Business Update
12:40pm
424B3
goe5a
8 Nov 23
Prospectus supplement
4:04pm
424B3
05e aydzbn7dsg2p1hkv
8 Nov 23
Prospectus supplement
4:03pm
424B3
q84z867q94 eju70th2a
8 Nov 23
Prospectus supplement
4:01pm
8-K
EX-99.1
2v931ou33goz 2y
10 Aug 23
GeoVax Reports 2023 Second Quarter Financial Results
9:45am
8-K
EX-10.1
j5sb 0m6dsyzevaqqfqe
18 Jul 23
Entry into a Material Definitive Agreement
4:27pm